About The Position

Associate Principal Scientist- Value & Implementation - Outcomes Research, Oncology – Assets, Biomarker and Portfolio Real-world evidence (RWE) This position resides within our company's Value and Implementation (V&I) Oncology organization, which leads the execution of value evidence plan and delivery of strategic real-world evidence (RWE) capabilities to inform healthcare decision making. The Associate Principal Scientist will provide US and ex-US outcomes research support for Oncology programs. The position reports to the Senior Director responsible for Portfolio Real-world Evidence (RWE) in Oncology. Position objectives To design and execute observational and real-world studies, designed to demonstrate the value of new products in support of HTA, reimbursement, provider, payer and patient decision-making. To provide outcomes research leadership and consultation on advanced evidence generation methods, HTA guidelines and asset positioning opportunities. To inform and contribute to the value evidence plan and associated studies which demonstrate clinical, economic, and patient-centered value. The work will support one or more assets, To support the implementation of RWE capability maturity model for global excellence in RWE generation, in partnership with local RWE experts and stakeholders. To communicate findings from the research to relevant internal and external audiences, including supporting the development of communication resources. To generate value evidence required by HTA/payers globally including value dossiers, evidence synthesis, clinical trial value endpoints, and support economic modeling globally (for assigned assets). Position accountabilities To collaborate with internal stakeholders to ensure research priorities and plans are aligned To communicate with relevant external audiences including regulators, health care providers, HTAs, patient organizations, and others To design and execute outcomes research studies, in collaboration with scientific leaders, patient organizations, academic medical centers, health systems, research organizations, database holders, and others. To prepare outcomes research protocols, statistical analysis plans, and clinical study reports. To communicate findings effectively at scientific conferences, in publications, dossiers, and by other means. To maintain awareness of scientific developments in the field Expertise in observational study best practices, fitness-for-use,real world evidence frameworks, and global guidelines on the conduct of observational research.

Requirements

  • Doctoral or Masters’ degree from a recognized school of medicine, public health, management, epidemiology, biostatistics, health policy, pharmacy, economics or related discipline
  • Expertise/experience in the design and implementation of real-world evidence
  • A track record of scientific presentations and publications.
  • 3+ years relevant experience if Masters’ degree only
  • Expertise in observational study best practices, fitness-for-use,real world evidence frameworks, and global guidelines on the conduct of observational research.

Nice To Haves

  • Doctoral degree
  • Experience in Oncology related outcomes research, epidemiology or health economics preferred.
  • Patient reported outcomes

Responsibilities

  • To design and execute observational and real-world studies, designed to demonstrate the value of new products in support of HTA, reimbursement, provider, payer and patient decision-making.
  • To provide outcomes research leadership and consultation on advanced evidence generation methods, HTA guidelines and asset positioning opportunities.
  • To inform and contribute to the value evidence plan and associated studies which demonstrate clinical, economic, and patient-centered value.
  • To support the implementation of RWE capability maturity model for global excellence in RWE generation, in partnership with local RWE experts and stakeholders.
  • To communicate findings from the research to relevant internal and external audiences, including supporting the development of communication resources.
  • To generate value evidence required by HTA/payers globally including value dossiers, evidence synthesis, clinical trial value endpoints, and support economic modeling globally (for assigned assets).
  • To collaborate with internal stakeholders to ensure research priorities and plans are aligned
  • To communicate with relevant external audiences including regulators, health care providers, HTAs, patient organizations, and others
  • To design and execute outcomes research studies, in collaboration with scientific leaders, patient organizations, academic medical centers, health systems, research organizations, database holders, and others.
  • To prepare outcomes research protocols, statistical analysis plans, and clinical study reports.
  • To communicate findings effectively at scientific conferences, in publications, dossiers, and by other means.
  • To maintain awareness of scientific developments in the field

Benefits

  • medical, dental, vision healthcare and other insurance benefits (for employee and family)
  • retirement benefits, including 401(k)
  • paid holidays
  • vacation, and compassionate and sick days
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service